IP Library Granted Patent US 8,329,192
Granted Patent B2
US 8,329,192 · App. 10/945,847 · Granted Dec 11, 2012

Patent

Assignee: Epitopix LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,329,192
App. No.
10/945,847
Granted
Dec 11, 2012
Kind
B2
Abstract

The present invention provides isolated metal regulated polypeptides obtainable from a Campylobacter spp., and compositions including the polypeptides. The present invention also includes methods for using the compositions disclosed herein, including methods for treating in infection in a subject, for treating a condition caused by a Campylobacter spp., and for decreasing colonization of an animal.

Claims (6)

1. A method of administering to an animal colonized by or at risk of being colonized by Campylobacter jejuni , an amount of a composition comprising isolated iron-regulated polypeptides obtainable from Campylobacter jejuni when incubated in a culture medium comprising an iron chelator and not obtainable when grown in the culture medium without the iron chelator, wherein the amount is an amount effective to decrease colonization of the intestinal tract of the animal by Campylobacter jejuni , and wherein the isolated iron-regulated polypeptides have molecular weights of between 150 kDa and 152 kDa, between 143 kDa and 145 kDa, between 123 kDa and 125 kDa, between 88 kDa and 90 kDa, between 73 kDa and 75 kDa, between 69 kDa and 71 kDa, between 51 kDa and 53 kDa, between 50 kDa and 52 kDa, and between 38 kDa and 40 kDa as determined by 10% SDS-PAGE.

2. A method of reducing fecal shedding of Campylobacter jejuni in an animal colonized by Campylobacter jejuni comprising administering to the animal an amount of a composition comprising isolated iron-regulated polypeptides obtainable from the Campylobacter jejuni when incubated in a culture medium comprising an iron chelator and not obtainable when grown in the culture medium without the iron chelator, wherein the amount is an amount effective to reduce the fecal shedding and wherein the isolated iron-regulated polypeptides have molecular weights of between 150 kDa and 152 kDa, between 143 kDa and 145 kDa, between 123 kDa and 125 kDa, between 88 kDa and 90 kDa, between 73 kDa and 75 kDa, between 69 kDa and 71 kDa, between 51 kDa and 53 kDa, between 50 kDa and 52 kDa, and between 38 kDa and 40 kDa as determined by 10% SDS-PAGE.

3. The method of claim 1 , wherein the animal is a mammal or a bird.

4. The method of claim 2 , wherein the animal is a mammal or a bird.

5. The method of claim 1 , wherein the Campylobacter jejuni is C. jejuni ATCC strain PTA-6215.

6. The method of claim 2 , wherein the Campylobacter jejuni is C. jejuni ATCC strain PTA-6215.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2024
From: EPITOPIX, LLC
To: VAXXINOVA US, INC.
Reel/Frame 066488/0734 →
SECURITY AGREEMENT Recorded Feb 19, 2010
From: WP HOLDING, INC.; WLSI HOLDING, INC.; LIFE-SCIENCE INNOVATIONS, LLC; EPITOPIX, LLC
To: UNITED FCS, PCA
Reel/Frame 023957/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2009
From: EMERY, DARYLL A.; STRAUB, DARREN E.
To: EPITOPIX LLC.
Reel/Frame 022303/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2005
From: WILLMAR POULTRY COMPANY, INC.
To: EPITOPIX LLC
Reel/Frame 016274/0735 →
Continuity (2)
Provisional Application 60504119 · Sep 19, 2003
Related Publication 20050095682A1 · May 5, 2005